WuXi AppTec Co Ltd (603259)
Shanghai Stock Exchange · China · prices in CNY · close of 22 Oct 2026
Key indicators
| Last close | CNY 141.31 |
|---|---|
| 52-week range | 87.09 – 173.60 |
| Return, 1 month / 3 months | −15.8% / +12.2% |
| Return, 1 year / 3 years | +40.0% / +67.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 42.3% |
| Worst drawdown (1 year) | -22.4% |
| Average daily value traded | 7,556.96M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
WuXi AppTec is a contract research, development and manufacturing organisation serving pharmaceutical and biotechnology companies. It helps customers discover and develop small molecule drugs, biologics and cell and gene therapies, and it manufactures active pharmaceutical ingredients and finished products. Its services cover laboratory testing, preclinical safety assessment, clinical trial support and commercial production. The company is based in China and works with drug developers in many countries around the world.
The shares are listed on the Shanghai Stock Exchange in China under the code 603259, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
WuXi AppTec Co Ltd (603259) trades on the Shanghai Stock Exchange in China. It last closed at CNY 141.31 on 22 October 2026.
Its price-based Market X-Ray is 89 out of 100 (a strong price profile), ranking 9 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.0% and over the last three months it rose 12.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 97 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 20.0% | ||
| From 52-week high | -15.9% | ||
| Momentum | 90 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 12.2% | ||
| 6-month return | 42.4% | ||
| 12-month return, skipping the last month | 66.4% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.4% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 7,556.96M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −8.5% |
|---|---|
| 1 month | −15.8% |
| 3 months | +12.2% |
| 6 months | +42.4% |
| 1 year | +40.0% |
| 3 years | +67.0% |
| 5 years | +2.9% |
Signals
| 50-day / 200-day average | 157.71 / 117.74 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.14 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Jun 2023 | CNY 0.8927 |
| 9 Jun 2022 | CNY 0.5174 |
| 8 Jun 2021 | CNY 0.4356 |
| 4 Jun 2020 | CNY 0.4718 |
| 2 Jul 2019 | CNY 0.8120 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.